Drug Approval

Drug Approval is a regulatory decision process within pharmaceutical governance that authorizes the commercialization of a medicinal product following demonstration of its safety, efficacy, and quality in accordance with established legal and scientific standards.

2.2K

Publications

98.2K

Citations

5.3K

Authors

1.9K

Institutions

Publications per year

2017–2026

747

Authors

5.3K

  1. AS
    Aaron S. Kesselheim

    Brigham and Women's Hospital, United States

    81 publications · 4.7K citations

    40

    h-index

  2. JS
    Joseph S. Ross

    Yale University, United States

    39 publications · 2.2K citations

    24

    h-index

  3. JA
    Jerry Avorn

    Brigham and Women's Hospital, United States

    28 publications · 1.7K citations

    20

    h-index

  4. HG
    Hubert G. M. Leufkens

    Utrecht University, Netherlands

    20 publications · 892 citations

    17

    h-index

  5. HN
    Huseyin Naci

    London School of Economics and Political Science, United Kingdom

    15 publications · 800 citations

    15

    h-index

1–5 of 5.3K

Venues

  1. New England Journal of Medicine

    NEJM · 80 publications · 5.9K citations

    42

    h-index

  2. PubMed

    Repository · 139 publications · 4.8K citations

    37

    h-index

  3. Clinical Pharmacology & Therapeutics

    CPT · 88 publications · 4K citations

    34

    h-index

  4. Drugs

    34 publications · 3.1K citations

    31

    h-index

  5. JAMA

    58 publications · 5.4K citations

    28

    h-index

1–5